熱門資訊> 正文
AFRM、BILI和GOEV均为上市前输家
2024-04-23 20:17
- Losers: Abeona Therapeutics (ABEO) -48% provides regulatory update on Pz-cel.
- T2 Biosystems (TTOO) -16% files to sell common stock, warrants.
- Calix (CALX) -14% after Q1 earnings release.
- Sasol Ltd (SSL) -11% anticipates macro volatility to persist in Q4 FY24 amid geopolitical risks.
- mF International Ltd (MFI) -11%.
- Jetblue Airways Corp (JBLU) -10% after Q1 earnings release.
- Sunshine Biopharma (SBFM) -10%.
- YY Group Holding Limited Class A Ordinary Shares (YYGH) -9%.
- Xerox Holdings Corp (XRX) -8% after Q1 earnings release.
- Tungray Technologies Inc Class A Ordinary Shares (TRSG) -6%.
- Moolec Science (MLEC) -8%.
- Cadence Design Systems (CDNS) -6% after Q1 earnings release.
- Bilibili (BILI) -6%.
- Redwoods Acquisition Corp (RWOD) -6%.
- Canoo (GOEV) -5%.
- Affirm Holdings (AFRM) -4%.
More on pre-market losers & stocks.
- Affirm: Acceleration Across The Board
- Affirm Holdings: Hard To Win Against Block, PayPal And Klarna, Amid Substantial Losses
- Affirm: Stunning Acceleration In Growth And Margin Expansion (Rating Upgrade)
- Bilibili reiterated a Buy as BofA sees in-line results amid better ad business, game launches
- Canoo repositioned for significant growth despite funding challenges - analyst
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
